Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-13

FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Osphena (ospemifene) from Duchesnay USA, Inc., expanding/updating its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Osphena (ospemifene)

Snippet

SUPPL AP for OSPHENA (OSPEMIFENE)